Nasdaq

First ReWalk Personal Exoskeleton Claim Paid by Medicare

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 05, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), a leading provider of innovative technologies that enable ...
Business Insider

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the ...
Business Insider

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

Additional progress with traditional Medicare claim approvals has accelerated timelines to payment in 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd ...
Seeking Alpha

Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, March 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (RWLK), (“ReWalk” or the “Company”), a leading provider of innovative technologies that ...
Yahoo

Next steps: Technology opens new options for greater mobility

Doug Boswell trying out the ReWalk Exoskeleton to take his first steps after his T-11 spinal cord injury. (Photo by David Middleton/MU Extension Courtesy Appointment, Missouri AgrAbility Level 2 ...
Nasdaq

Lifeward Achieves European Approval for Latest ReWalk Exoskeleton

Lifeward Ltd. LFWD recently announced that it has received CE mark approval for the ReWalk 7 Personal Exoskeleton. Following this approval, the seventh generation of the ReWalk is now cleared for ...